KB Degn, B Brock, CB Juhl, CB Djurhuus, J … - Diabetes, 2004 - Am Diabetes Assoc This study assessed whether glucose-dependent insulin secretion and overall
counterregulatory response are preserved during hypoglycemia in the presence of
exenatide. Twelve healthy fasted volunteers were randomized in a ... Cited by 122 - Related articles - BL Direct - All 6 versions
JJ Meier, MA Nauck - Diabetes/Metabolism Reviews - interscience.wiley.com Post-translational proteolytic processing of the preproglucagon gene in the gut
results in the formation of glucagon-like peptide 1 (GLP-1). Owing to its
glucose-dependent insulinotropic effect, this hormone was postulated to ... Cited by 73 - Related articles - All 3 versions
- ►endojournals.org JM Egan, GS Meneilly, JF Habener, D Elahi - Journal of Clinical Endocrinology & Metabolism, 2002 - Endocrine Soc The insulinotropic hormone, glucagon-like peptide-1 (GLP-1), is being examined
as a potential new agent for treatment in type 2 diabetic patients. Whereas the
insulinotropic properties of this peptide are well established, another ... Cited by 60 - Related articles - BL Direct - All 8 versions
- ►physiology.org RL Prigeon, S Quddusi, B Paty, DA D'Alessio - American Journal of Physiology- Endocrinology And …, 2003 - Am Physiological Soc Glucagon-like peptide-1 (GLP-1) is an intestinal hormone that stimulates insulin
secretion and decreases glucagon release. It has been hypothesized that GLP-1
also reduces glycemia independent of its effect on islet hormones. Based on ... Cited by 40 - Related articles - BL Direct - All 3 versions
- ►physiology.org M Nishizawa, MC Moore, M Shiota, SM … - American Journal of Physiology- Endocrinology And …, 2003 - Am Physiological Soc Arteriovenous difference and tracer ([3- 3 H]glucose) techniques were used in
42-h-fasted conscious dogs to identify any insulin-like effects of intraportally
administered glucagon-like peptide 1-(7-36)amide (GLP-1). Each study ... Cited by 38 - Related articles - BL Direct - All 4 versions
- ►physiology.org DA D'Alessio, TP Vahl - American Journal of Physiology- Endocrinology And …, 2004 - Am Physiological Soc Glucagon-like peptide 1 (GLP-1) is a product of proglucagon that is secreted by
specialized intestinal endocrine cells after meals. GLP-1 is insulinotropic and
plays a role in the incretin effect, the augmented insulin response ... Cited by 36 - Related articles - BL Direct - All 4 versions
- ►endocrinology-journals.org [PDF] MA Luque, N Gonzalez, L Marquez, A Acitores … - Journal of Endocrinology, 2002 - Soc Endocrinology Glucagon-like peptide-1 (GLP-1) has been shown to have insulin-like effects upon
the metabolism of glucose in rat liver, muscle and fat, and on that of lipids in
rat and human adipocytes. These actions seem to be exerted through specific ... Cited by 33 - Related articles - BL Direct - All 4 versions
MT Behme, J Dupré, TJ McDonald - BMC Endocrine Disorders, 2003 - biomedcentral.com Dose-finding studies were carried out to establish mid range doses for delay of
gastric emptying indicated by postponement of pancreatic polypeptide responses
after meals. The selected dose of 0.63 micrograms/kg GLP-1 was administered ... Cited by 30 - Related articles - Cached - All 7 versions
M Camilleri - Gastroenterology, 2006 - Elsevier The responses to ingestion of food are complex and have been traditionally
considered in 3 phases: cephalic, gastric, and intestinal. While this allows the
different functions to be reduced to manageable descriptions, it is ... Cited by 23 - Related articles - All 15 versions
